Pharmacoepidemiology and drug utilization of benzodiazepines and z-drugs among adults in Manitoba, Canada
dc.contributor.author | Brandt, Jaden | |
dc.contributor.examiningcommittee | Alessi-Severini, Silvia (Pharmacy) Zelenitsky, Sheryl (Pharmacy) Singer, Alexander (Family Medicine) Chateau, Dan (Community Health Sciences) | en_US |
dc.contributor.supervisor | Leong, Christine (Pharmacy) | en_US |
dc.date.accessioned | 2019-01-15T19:56:43Z | |
dc.date.available | 2019-01-15T19:56:43Z | |
dc.date.issued | 2018 | en_US |
dc.date.submitted | 2018-12-22T19:46:59Z | en |
dc.date.submitted | 2019-01-07T21:08:48Z | en |
dc.date.submitted | 2019-01-15T17:20:58Z | en |
dc.degree.discipline | Pharmacy | en_US |
dc.degree.level | Master of Science (M.Sc.) | en_US |
dc.description.abstract | Background: The use of benzodiazepines and z-drugs remains controversial given their potential for misuse and harm. Investigation of their use in Manitoba remains important for monitoring and improving prescribing patterns. Methods: Administrative data was used to conduct i) drug utilization study from 2001-2016, and ii) incident-user cohort study of patients with anxiety/insomnia. Results: i) Z-drug use increased on all measures while only dose intensity increased for benzodiazepines. Higher utilization occurred among females and those ≥65 years. ii) The proportion of patients who became long-term users (>6months) in their first episode of use ranged from 4.5-9.6%. Males, older age, socioeconomically deprived, use of opioids or psychotropic agents, and poor physical health, were associated with long-term use. Conclusion: While less than one in 10 were considered a long-term user of these agents, further investigation into whether specific factors associated with long-term use requires consideration during the prescribing of these agents is warranted. | en_US |
dc.description.note | February 2019 | en_US |
dc.identifier.citation | Drugs R D 17(4) 493-507 | en_US |
dc.identifier.citation | Clinical Drug Investigation 38(7) 565-572 | en_US |
dc.identifier.citation | Journal of Population Therapeutics and Clinical Pharmacology 26(1) 1-17 | en_US |
dc.identifier.uri | http://hdl.handle.net/1993/33722 | |
dc.language.iso | eng | en_US |
dc.rights | open access | en_US |
dc.subject | Benzodiazepines | en_US |
dc.subject | Epidemiology | en_US |
dc.subject | Anxiety | en_US |
dc.subject | Insomnia | en_US |
dc.subject | Drug utilization | en_US |
dc.title | Pharmacoepidemiology and drug utilization of benzodiazepines and z-drugs among adults in Manitoba, Canada | en_US |
dc.type | master thesis | en_US |